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Cardiac myosin binding protein-C (cMyBP-C) phosphorylation is an important regulator
of contractile function, however, its contributions to length-dependent changes in
cross-bridge (XB) kinetics is unknown. Therefore, we performed mechanical experiments
to quantify contractile function in detergent-skinned ventricular preparations isolated from
wild-type (WT) hearts, and hearts expressing non-phosphorylatable cMyBP-C [Ser to Ala
substitutions at residues Ser273, Ser282, and Ser302 (i.e., 3SA)], at sarcomere length
(SL) 1.9µm or 2.1µm, prior and following protein kinase A (PKA) treatment. Steady-state
force generation measurements revealed a blunting in the length-dependent increase in
myofilament Ca2+-sensitivity of force generation (pCa50) following an increase in SL in
3SA skinned myocardium compared to WT skinned myocardium. Dynamic XB behavior
was assessed at submaximal Ca2+-activations by imposing an acute rapid stretch of
2% of initial muscle length, and measuring both the magnitudes and rates of resultant
phases of force decay due to strain-induced XB detachment and delayed force rise due
to recruitment of additional XBs with increased SL (i.e., stretch activation). The magnitude
(P2) and rate of XB detachment (krel) following stretch was significantly reduced in 3SA
skinned myocardium compared to WT skinned myocardium at short and long SL, and
prior to and following PKA treatment. Furthermore, the length-dependent acceleration of
krel due to decreased SL that was observed in WT skinned myocardium was abolished
in 3SA skinned myocardium. PKA treatment accelerated the rate of XB recruitment (kdf)
following stretch at both SL’s in WT but not in 3SA skinned myocardium. The amplitude
of the enhancement in force generation above initial pre-stretch steady-state levels (P3)
was not different between WT and 3SA skinned myocardium at any condition measured.
However, the magnitude of the entire delayed force phase which can dip below initial
pre-stretch steady-state levels (Pdf) was significantly lower in 3SA skinned myocardium
under all conditions, in part due to a reduced magnitude of XB detachment (P2) in 3SA
skinnedmyocardium compared toWT skinnedmyocardium. These findings demonstrate
that cMyBP-C phospho-ablation regulates SL- and PKA-mediated effects on XB kinetics
in the myocardium, which would be expected to contribute to the regulation of the
Frank-Starling mechanism.
Keywords: cardiac myosin binding protein-C, phosphorylation, protein kinase A, stretch-activation, cross-bridge
kinetics, skinned myocardium
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INTRODUCTION
Two important physiological mechanisms by which the heart
modulates its ability to increase the strength and rate of
contraction are length-dependent changes in the contractile
function of cardiac muscle (Ter Keurs et al., 1980), and enhanced
activation of the β-adrenergic signaling pathway (Kranias
and Solaro, 1982). At the whole-heart level, length-dependent
activation (LDA) increases ventricular pressure development in
response to increased ventricular filling i.e., an increased stretch
of the ventricular muscle wall (Allen and Kentish, 1985; De
Tombe et al., 2010)—a phenomenon that drives the Frank-
Starling Law of the heart (Solaro, 2007). In cardiac myocytes LDA
is reflected as an enhancement in force generation in response to
an increase in sarcomere length (SL). At the myofilament level,
factors that modulate LDA include changes in lattice spacing
(Fuchs and Smith, 2001), myofilament responsiveness to [Ca2+]
(Konhilas et al., 2002; Cazorla et al., 2006), rates of cross-
bridge (XB) cycling (Adhikari et al., 2004; Moss et al., 2004;
Biesiadecki et al., 2014), and a complex interplay between XB-
induced cooperative activation and cooperative deactivation of
thin filaments (Hanft et al., 2008).
In addition, increased β-adrenergic signaling in response
to increased cardiac workload increase levels of cyclic AMP
and protein kinase A (PKA) (Kranias and Solaro, 1982),
resulting in increased phosphorylation of proteins involved in
excitation-contraction coupling such as phospholamban, L-type
Ca2+ channels, and ryanodine receptors which contribute to
enhanced systolic and diastolic function (Bers, 2002). At the
myofilament level, PKA targets key regulatory proteins such as
cardiac troponin I (cTnI) (Kentish et al., 2001; Layland et al.,
2004), titin (Fukuda and Granzier, 2005), and cardiac myosin
binding protein-C (cMyBP-C) (Garvey et al., 1988; Stelzer
et al., 2007b; Barefield and Sadayappan, 2010). PKA-mediated
phosphorylation of myofilament proteins in turn affects LDA
by impacting multiple processes that control the rates of thin
filament deactivation and XB cycling (reviewed by Biesiadecki
et al., 2014), and the rates of XB recruitment and force generation
(reviewed by Moss et al., 2015). In particular, the role of
cTnI phosphorylation in modulating LDA has been fairly well
investigated; PKA phosphorylation of residues Ser23/24 on cTnI
has been shown to decrease myofilament Ca2+ sensitivity of force
generation (Solaro et al., 1976; Robertson et al., 1982; Fentzke
et al., 1999). Recently, it has also been suggested that other
phosphorylatable residues on cTnI such as Thr 143 may also
play a role in modulating LDA (Tachampa et al., 2007; Wijnker
et al., 2014). The effects of PKA phosphorylation (which targets
both cTnI and cMyBP-C) on XB kinetics are less clear with
some showing a decrease (Hanft and Mcdonald, 2009, 2010), no
change (Janssen and De Tombe, 1997; Walker et al., 2011) or an
acceleration (Stelzer et al., 2006d; Cheng et al., 2013; Gresham
et al., 2014). Furthermore, PKA-mediated phosphorylation led to
Abbreviations: cMyBP-C, cardiac myosin binding protein-C; WT, wild-type; XB,
cross-bridge; ktr, rate of force redevelopment; krel, rate of XB detachment; P2:
magnitude of XB detachment; kdf, rate of XB recruitment; Pdf, magnitude of
delayed force development; PKA, protein kinase A.
more pronounced LDA in myocardial preparations lacking the
titin’s N2B region due to enhanced length-dependent changes
in myofilament Ca2+ sensitivity and passive tension—suggesting
a role for titin in modulating LDA (Lee et al., 2013). It has
been suggested that cMyBP-C phosphorylation also plays a
role in modulation of length-dependent changes in steady-state
contractile function (Cazorla et al., 2006; Chen et al., 2010;
Kumar et al., 2015), however, the contribution of cMyBP-C
phosphorylation in modulating length-dependent changes in
myofilament XB kinetics is still unknown.
Results from earlier investigations provide strong evidence for
a significant role for cMyBP-C phosphorylation in modulating
length-dependent changes in XB kinetics. Specifically, cMyBP-
C phosphorylation has been shown to increase the proximity
between myosin heads and actin (Colson et al., 2008), and also
regulates key aspects of XB behavior that are known to impact
LDA (Hanft et al., 2008) such as the rates of XB detachment
and XB recruitment during Ca2+ activation (Stelzer et al., 2006c;
Lecarpentier et al., 2008; Tong et al., 2008; Coulton and Stelzer,
2012; Michalek et al., 2013; Wang et al., 2014). Furthermore,
recent studies show that increased cMyBP-C phosphorylation
augments force generation and the amplitude of the cardiac
twitches in intact cardiac preparations (Tong et al., 2015),
and modulates in vivo contractile and hemodynamic properties
by enhancing the systolic pressure development and diastolic
pressure relaxation (Rosas et al., 2015; Gresham and Stelzer,
2016). We recently demonstrated that transgenic (TG) mice
expressing non-phosphorylatable cMyBP-C containing Ser to
Ala substitutions at residues Ser273, Ser282, and Ser302 (i.e.,
3SA, Tong et al., 2008; Gresham and Stelzer, 2016), displayed
depressed accelerations of in vivo left-ventricular pressure
development and pressure relaxation in response to acute β-
agonist infusion, demonstrating that cMyBP-C phosphorylation
is a primary mediator of the cardiac contractile response to
increased β-adrenergic stimulation (Gresham and Stelzer, 2016).
Therefore, to define the precise molecular mechanisms of
cMyBP-C phosphorylation in modulating length-dependent
changes in contractile function, we performed mechanical
experiments in skinned myocardium isolated from WT and 3SA
hearts at variable SL (1.9 and 2.1µm), prior to and following
PKA treatment. We utilized stretch-activation experiments to
probe dynamic XB behavior because stretch-activation, i.e., the
delayed force development resulting from the stretch of the
ventricular wall, has been proposed to be an intrinsic length-
sensing mechanism that plays a vital role in mediating LDA in
myocardial contraction on a beat-to-beat basis (Campbell and
Chandra, 2006; Stelzer and Moss, 2006). Specifically, imposing
a sudden rapid stretch on a muscle fiber during steady-state
isometric contraction elicits a multiphase force response which
exhibits an immediate increase in force that is proportional to
the magnitude of the imposed stretch. This initial rise in force
is due to the distortion of the elastic regions of the bound
XBs which then rapidly decays as the distorted XBs detach and
repopulate into the nondistorted state (Davis and Rodgers, 1995;
Piazzesi et al., 1997). This force decay phase is followed by a
slow, gradual force redevelopment phase due to stretch-induced
recruitment of additional XBs into the force-producing state
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(Lombardi et al., 1995; Dobbie et al., 1998) which is referred to
as the stretch-activation response (for alternative interpretations
of the stretch-activation phases and how they relate to various
XB models, refer to, Abbott and Steiger, 1977; Ford et al., 1977;
Lombardi et al., 1995; Piazzesi et al., 1997; Davis and Epstein,
2003; Kawai and Halvorson, 2007). It was long recognized that
cardiac muscle exhibits a prominent stretch-activation response
(Steiger, 1971), a phenomenon that contributes to significant
enhancement in force generation during the systolic ejection
(Vemuri et al., 1999; Davis et al., 2001), and also contributes
to the steepness of the length-tension relationship in cardiac
muscle (Allen and Kentish, 1985; Campbell and Chandra, 2006).
The phenomenon of stretch-activation is most pronounced at
low levels of Ca2+ activation, because under these conditions
relatively few XBs are strongly-bound to the thin filament,
and the majority of the actin binding sites are available for
recruitment and binding of additional XBs (Stelzer et al., 2006c).
Thus, stretch-activation consists of both the initial binding of
the XBs to the thin filament and the subsequent cooperative
recruitment of additional unbound XBs, thereby promoting
the propagation of activation of neighboring thin filament
regulatory subunits in response to a sudden stretch in muscle
length.
Our results demonstrate that cMyBP-C phospho-ablation
significantly slows the rate of XB detachment (krel) in response
to a rapid acute stretch, and also abolishes the acceleration
in krel due to decreased SL and PKA treatment that is
observed in WT skinned myocardium. Furthermore, our data
show that skinned myocardium isolated from 3SA hearts
displays a significantly reduced magnitude of stretch-induced
XB recruitment at either SL, or following PKA treatment
compared to WT skinned myocardium, suggesting that cMyBP-
C phosphorylation facilitates length-dependent changes in
cooperative XB recruitment and cycling. Thus, our data show
that cMyBP-C phosphorylation is a requisite for eliciting normal
length-dependent modulation of XB kinetics in the cardiac
sarcomere, and would be expected to contribute to the LDA and
consequent enhancement in the Frank-starling mechanism in
conditions of increased sympathetic drive (Hanft and Mcdonald,
2009).
MATERIALS AND METHODS
Ethical Approval and Animal Treatment
Protocols
All experiments described in this study were performed as
outlined in the Guide for the Care and Use of Laboratory Animals
(NIH Publication No. 85–23, Revised 1996), and were conducted
in accordance with the guidelines of the Institutional Animal
Care andUse Committee at the CaseWestern Reserve University.
Male and female wild-type (WT) and transgenic (TG) mice
expressing non-phosphorylatable cMyBP-C containing serine
(Ser) to alanine (Ala) substitutions at residues Ser273, Ser282, and
Ser302 (i.e., 3SA) on a cMyBP-C null background (Tong et al.,
2008; Gresham and Stelzer, 2016), aged 3–6 months (SV/129
strain) were used for the experiments.
Determination of Phosphorylation Status of
cMyBP-C and Other Sarcomeric Proteins
in WT and 3SA Myocardial Samples
Determination of myofilament protein phosphorylation status
was done by Western blot and Pro-Q Diamond phosphoprotein
stain (Life Technologies) as described previously (Gresham et al.,
2014; Mamidi et al., 2014). Isolation of cardiac myofibrils from
frozen mouse ventricles was performed as described previously
(Cheng et al., 2013; Gresham et al., 2014; Mamidi et al., 2015).
Frozen mouse ventricular tissue was thawed and homogenized in
fresh relaxing solution on the day of the experiment. Myofibrils
were chemically skinned for 15min using 1% Triton X-100 on
a mechanical rocker plate, centrifuged, and then resuspended
in fresh relaxing solution containing protease and phosphatase
inhibitors (PhosSTOP and cOmplete ULTRA Tablets; Roche
Applied Science, Indianapolis, IN, USA), and stored on ice until
further use. All solutions were brought to room temperature
(22◦C) for 10min before initiating the PKA phosphorylation
reaction. One hundred micro grams of WT and 3SA myofibrils
were incubated with the catalytic subunit of bovine PKA (Sigma-
Aldrich, St Louis, MO, USA) to a final concentration of 0.15 U
PKA/µgmyofibrils for 1 h at 30◦C (Gresham et al., 2014). Control
myofibrils were incubated under the same conditions without
PKA. Laemli buffer was added to stop the reaction and samples
were heated at 90◦C for 5min and stored at −20◦C until the
gels were run. For Western blot, 5µg of solubilized myofibrils
were loaded onto a 4–20% Tris-glycine gel (Lonza, Rockland,
ME, USA) and electrophoretically separated at 180V for 70min.
Proteins were transferred to PVDF membranes and incubated
overnight with one of the following primary antibodies: total
TnI (Cell Signaling Technology), TnI phospho-serine 23 and
24 (detects phosphorylation of Ser23 and Ser24 of TnI; Cell
Signaling), total cMyBP-C (Santa Cruz Biotechnology), cMyBP-
C phospho-serine 273, 282, or 302 (detects phosphorylation of
Ser273, S282, or Ser302 of cMyBP-C; 21st Century Biochemicals),
or HSC70 as a loading control (Santa Cruz Biotechnology).
Membranes were then incubated with appropriate secondary
antibodies and imaged. For estimating the total myofilament
protein phosphorylation, 2.5µg of myofibrils were separated
at 180V for 85min, fixed, and then stained with Pro-Q
phosphostain and imaged using a Typhoon gel scanner. Pro-
Q gels were counterstained with coomassie blue to determine
the total protein loaded. Densitometric scanning of the stained
gels was done using Image J software (U.S. National Institutes of
Health, Bethesda, MD, USA; Gresham et al., 2014).
Preparation of Skinned Myocardial
Preparations and Ca2+ Solutions for
Mechanical Experiments
Skinned myocardium was prepared as described previously
(Cheng et al., 2013; Gresham et al., 2014). In brief, ventricular
tissue was homogenized in a relaxing solution followed by
chemical-skinning for 1 h using 1% Triton-X 100 (Thermo
Scientific, Rockford, IL). Multicellular ventricular preparations
measuring ∼100µm in width and ∼400µm in length were
chosen for the experiments. The composition of various Ca2+
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activation solutions used for the experiments was calculated
using a computer program (Fabiato, 1988) and established
stability constants (Godt and Lindley, 1982). All solutions
contained the following (in mM): 14.5 creatine phosphate, 7
EGTA, and 20 Imidazole. The maximal activating solution (pCa
4.5; pCa= -log [Ca2+]free) also contained 65.45 KCl, 7.01 CaCl2;
5.27 MgCl2, 4.81 ATP, while the relaxing solution (pCa 9.0)
contained 72.45 KCl, 0.02 CaCl2; 5.42 MgCl2, 4.76 ATP. The pH
of the Ca2+ solutions was set to 7.0 and the ionic strength was
180mM. A range of pCa solutions (pCa 6.3 to 5.5), containing
varying amounts of [Ca2+]free, were then prepared by mixing
appropriate volumes of pCa 9.0 and 4.5 stock solutions, and all
the experiments were carried out at 23◦C.
Experimental Apparatus for Measurement
of Contractile Properties in Skinned
Myocardium
Chemically-skinned multicellular ventricular preparations were
mounted between a motor arm (312C; Aurora Scientific Inc.,
Aurora, Ontario, Canada) and a force transducer (403A; Aurora
Scientific Inc.) as described previously (Merkulov et al., 2012;
Cheng et al., 2013). Changes in the motor position and signals
from the force transducer were sampled at 2000Hz using
sarcomere length (SL) control software program (Campbell
and Moss, 2003). For all mechanical measurements, SL of the
ventricular preparations was set to either 1.9µm (short SL)
or 2.1µm (long SL) (Desjardins et al., 2012; Cheng et al.,
2013). Force-pCa relationships were generated by incubating the
skinned myocardial preparations in a range of pCa solutions
(i.e., pCa 6.3 to 4.5). The apparent cooperativity of force
development was estimated from the steepness of Hill plot
transformation of the force-pCa relationships (Mamidi et al.,
2014). The force-pCa data were fit using the equation P/Po =
[Ca2+]nH/(knH + [Ca2+]nH), where nH is the Hill coefficient and
k is the pCa required to produce half-maximal activation (i.e.,
pCa50; Gresham et al., 2014).
Measurement of the Rate of Force
Redevelopment (ktr)
ktr was measured in WT and 3SA skinned myocardium to
assess XB transitions from both the weakly- to strongly-bound
states and from the strongly- to weakly-bound states (Brenner
and Eisenberg, 1986; Campbell, 1997). A mechanical slack-
restretch protocol was used to measure ktr in the Ca
2+-activated
myocardial preparations as described previously (Stelzer et al.,
2006b; Chen et al., 2010; Cheng et al., 2013). Skinned
myocardial preparations were transferred from relaxing (pCa
9.0) to Ca2+ activating solutions (pCa ranging from 6.1 to
5.8) yielding ∼35% of maximal activation level, and when the
myocardial preparations attained a steady-state isometric force,
they were rapidly slackened by 20% of their original muscle
length and were held constant for 10ms. The slackening was
followed by a brief period of unloaded shortening resulting in
a rapid force decline due to the detachment of the strongly-
bound XBs. The myocardial preparations were then rapidly
stretched back to their original length and the time course of
force redevelopment was measured. ktr was estimated by linear
transformation of the half-time of force redevelopment, i.e., ktr =
0.693/t1/2, where t1/2 is the time (in milliseconds) taken to reach
the half maximal force of the ktr trace as described previously
(Merkulov et al., 2012; Cheng et al., 2013; Mamidi et al., 2015).
Baseline force was considered the point on the ktr trace where
force begins to redevelop following the slack-restretch maneuver,
and peak force development was considered the point in the ktr
trace where force plateaus and reaches a steady-state level.
Stretch Activation Experiments to
Determine Dynamic XB Contractile
Parameters
Stretch activation experiments were performed as described
earlier (Gollapudi et al., 2012; Cheng et al., 2013; Gresham et al.,
2014; Michael et al., 2014). Skinned myocardial preparations
were bathed in Ca2+ solutions yielding steady-state forces of
∼35% ofmaximal, and once themyocardial preparations reached
a steady-state force, they were then rapidly stretched by 2%
of their initial muscle length, held at the new length for 5 s,
and were then returned back to their initial muscle length. In
our experiments, high speed stretches (completed ∼ in 2ms)
were imposed so as to minimize the changes in XB populations
during the time of the imposed stretch in muscle length, so
that the stretch activation response observed was likely due
to the elastic properties of the XBs bound to actin prior to
the stretch (Stelzer et al., 2006c). The characteristic features
of the stretch activation responses/tension transients in cardiac
muscle have been described in detail elsewhere (Stelzer andMoss,
2006; Ford et al., 2010), and the stretch activation parameters
measured are shown in Figure 1. Different phases of the tension
transients elicited in response to step increases in length were
then analyzed individually as done previously to gain insights
into XB mechanics (Stelzer et al., 2006a,c,d, 2007b).
In brief, a sudden 2% stretch of muscle length causes an
instantaneous rise in force (P1), which is a result of strain of
strongly-bound XBs (Phase 1) and denotes XB stiffness (Stelzer
and Moss, 2006; Mamidi et al., 2014). The force then quickly
decays (Phase 2) due to a rapid detachment of the strained XBs
which equilibrate into a non-force generating state, with a rate
constant krel, an index of XB detachment. The minimum force
attained at the end of Phase 2 of the stretch activation response is
denoted by P2, and represents the magnitude of XB detachment
following stretch (Stelzer et al., 2006c). The amplitude P2 (i.e.,
the minimum force attained at the lowest point of the Phase 2
force decay, i.e., the nadir, just prior to the commencement of
Phase 3 delayed force development) can decline further than the
isometric pre-stretch force resulting in negative values, especially
following PKA treatment, which is likely due to an acceleration
in the rate of XB detachment in phase 2 (Stelzer et al., 2006d).
Following Phase 2, the preparations exhibit a gradual rise in force
development (Phase 3), with a rate constant kdf, due to stretch-
induced recruitment of additional XBs into the force-generating
state, and the amplitude of Phase 3 is an index of the magnitude
of XB recruitment (Stelzer et al., 2006c; Gresham et al., 2014). The
new peak of the steady-state force, which is higher than the initial
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FIGURE 1 | Effect of PKA treatment on the stretch activation responses in WT and 3SA skinned myocardium. Traces of representative force responses
elicited at ∼35% of maximal Ca2+ activation level by a sudden 2% stretch in muscle length (ML) in isometrically-contracting (A) WT and (B) cMyBP-C
phospho-ablated (i.e., 3SA) myocardial preparations prior to (black) and following incubation with PKA (red). In (A), highlighted are the important phases of the force
transients and the various stretch activation parameters that are derived from the elicited force response (see Materials and Methods). Phase 1 represents the
immediate increase in force in response to the sudden increase in ML. P1 is the magnitude of the immediate force response and is measured from the pre-stretch
isometric steady-state force to the peak of phase 1, and it represents the magnitude of XB stiffness. Phase 2 represents the rapid decay in force with a dynamic rate
constant krel and is an index of the rate of XB detachment. P2 represents the minimum force attained at the end of Phase 2 of the stretch-activation response and is
an index of the magnitude of XB detachment. Phase 3 represents the delayed force development with a dynamic rate constant kdf and is an index of the rate of XB
recruitment. P3 represents the new steady-state force attained in response to the imposed stretch in muscle length and is an index of force enhancement above initial
pre-stretch isometric levels. Pdf represents the amplitude of the delayed force development and is an index of the overall number of XBs being recruited into the
force-bearing state in response to a sudden 2% stretch in ML i.e., it represents the magnitude of XB recruitment. PKA treatment significantly accelerated both krel and
kdf in WT skinned myocardium but not in 3SA skinned myocardium. AU, arbitrary units.
steady-state force (i.e., the pre-stretch force), attained in response
to the increase in muscle length is indicated by P3 (Figure 1A).
The sum of all XBs recruited by a sudden 2% stretch in muscle
length in an isometrically-contracting myocardial preparation
can be assessed by measuring the amplitude of the delayed force
response of Phase 3 (Stelzer et al., 2006c). When P2 values are
negative, the trough-to-peak amplitude of Phase 3 (i.e., Pdf)
exceeds that of P3, and therefore, in these cases Pdf represents
the sum of all XB recruitment in Phase 3 due to stretch (Stelzer
et al., 2006d). As the level of Ca2+ activation increases, P3 and
Pdf decrease because a greater number of XBs are already bound
to actin prior to the stretch and fewer XBs are now available in
the non-force generating pool for recruitment into the force-
generating pool upon a stretch in muscle length (Stelzer and
Moss, 2006).
Stretch activation amplitudes were measured manually by
analyzing the different phases of the stretch activation transients.
The different stretch activation amplitudes were normalized
to pre-stretch Ca2+-activated force to facilitate comparisons
between preparations that develop different amounts of absolute
force, and the Ca2+-activation levels as done before (Stelzer
et al., 2006d, 2007b). Thus, the amplitudes of all parameters
measured are expressed as a fraction of the total pre-stretch forces
(Table 2; Stelzer et al., 2007b). Stretch activation amplitudes were
measured individually by manually fitting different phases of the
tension transients (Stelzer et al., 2006d, 2007b) as follows and are
shown in Figure 1A.
P1: measured from the pre-stretch steady-state force to the
peak of phase 1
P2: measured from the pre-stretch steady-state force to the
minimum force value attained at the end of phase 2.
P3: measured from the pre-stretch steady-state force to the
peak force value of the delayed force attained in phase 3.
Pdf: is the difference between P3 and P2
krel was measured by fitting a single exponential to the time
course of force decay using the formula: y = a (-1+ exp (-k1×x))
where “a” is the amplitude of the single exponential phase and k1
is the rate constant of the force decay.
Similar to ktr measurements, kdf was estimated by linear
transformation of the half-time of force redevelopment, i.e.,
kdf = 0.693/t1/2, where t1/2 is the time (in milliseconds) taken
from the nadir (i.e., the point of force reuptake at the end of phase
2) to achievement of the half maximal force of phase 3 of the force
response shown in Figure 1, where maximal force is indicated by
a plateau region in phase 3 i.e., P3. Thus, kdf represents the rate of
recruitment of all XBs that give rise to the delayed force transient
following stretch (i.e., Pdf).
Following incubation with PKA, the stretch activation
experiments were repeated. Because PKA treatment decreases the
myofilament Ca2+ sensitivity of force generation, we used a pCa
solution with slightly higher [Ca2+]free to match the activation
levels prior to PKA treatment (Stelzer et al., 2006d, 2007b).
Data Analysis
All data are reported as mean ± SEM. Steady-state and dynamic
contractile parameters were analyzed using a three-way analysis
of variance (ANOVA) by fitting linear models of three factors
using the R statistical program (R Core Team, 2013). One factor
in this analysis was cMyBP-C phosphorylation (WT or 3SA),
the second was PKA treatment (-PKA or +PKA), and the third
was SL (SL 1.9 or 2.1µm). Using this analysis, we assessed
the three-way and the two-way interaction effects. When the
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interaction effects were not significant, we interpreted the main
effects due to cMyBP-C phosphorylation, PKA, or SL. To probe
the cause for the interaction or main effects, post-hoc multiple
pairwise comparisons were made using Fisher’s Least Significant
Difference (Fisher’s LSD) method as done previously (Ford et al.,
2012). The criterion for statistical significance was set at P <
0.05, and the asterisks in figures and tables represent statistical
significance using post-hoc Fisher’s LSD tests.
RESULTS
Effect of cMyBP-C Phospho-Ablation on
the Isoform Expression and
Phosphorylation Status of Sarcomeric
Proteins
To determine the impact of TG expression of 3SA on
isoform expression and phosphorylation status of key regulatory
sarcomeric proteins, cardiac samples isolated from WT and
3SA heart were analyzed by Western blot and Pro-Q Diamond
phospho-stain analysis (Figure 2). The myocardial expression of
3SA cMyBP-C was determined to be ∼73 ± 8% of the cMyBP-C
content present in the WT samples, as reported earlier (Tong
et al., 2008; Gresham and Stelzer, 2016). Western blot analysis
(Figure 2A) shows no differences in the phosphorylation levels
of cTnI PKA residues Ser23/24 between WT and 3SA samples,
but as expected the phosphorylation of cMyBP-C at residues
Ser273, Ser282, and Ser302 was absent in 3SA samples confirming
phospho-ablation of all three PKA-phosphorylatable Ser residues
in the M-domain of cMyBP-C (Gresham and Stelzer, 2016).
Ventricular samples from WT and 3SA hearts were also
stained with Pro-Q Diamond to assess the impact of 3SA
expression on the phosphorylation status of other myofilament
regulatory proteins (Figures 2B,C). Our results show that
the expression and phosphorylation levels of sarcomeric
proteins such as troponin T and regulatory light chain were
not significantly different between WT and 3SA samples
(Figures 2B,C).
To determine the effect of cMyBP-C phospho-ablation on
PKA-mediated phosphorylation of myofilament proteins, WT
and 3SA samples were analyzed by Western blot and Pro-Q
Diamond staining following incubation with PKA for 1 h at
30◦C (Tong et al., 2008; Gresham et al., 2014). PKA treatment
enhanced phosphorylation of cTnI to a similar extent in both
WT and 3SA samples (Figure 2C). In contrast, PKA-mediated
enhancement of phosphorylation of cMyBP-Cwas evident inWT
samples but not in 3SA samples (Figures 2A–C), demonstrating
that PKA-mediated phosphorylation of cMyBP-C was abolished
in 3SA samples.
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in
Steady-State Force Generation
To assess the impact of cMyBP-C phospho-ablation on SL-
dependent changes in thin-filament activation, steady-state
Ca2+-activated force generation was measured at SL 1.9 and
2.1µm in WT and 3SA myocardial preparations (values are
shown in Table 1). We recently demonstrated (Gresham et al.,
2014) that steady-state and dynamic contractile parameters
of skinned myocardium isolated from WT hearts and TG
hearts expressing un-mutated cMyBP-C on a null cMyBP-C
background (Tong et al., 2008; i.e., TGWT), are not different
at baseline and following PKA incubation. Thus, in this study
we performed mechanical measurements on skinned myocardial
preparations isolated fromWT and 3SA hearts.
Increasing SL from 1.9 to 2.1µm enhanced force generation
in WT and 3SA skinned myocardium to a similar extent as
demonstrated by an increase in both maximal force generation
(Fmax, measured at pCa4.5) and minimal force generation (Fmin,
measured at pCa 9.0; Table 1). pCa50 was also significantly
increased at SL 2.1µm compared to 1.9µm in both WT and
3SA groups (Figure 3; Table 1), indicating that myofilament
Ca2+ sensitivity was increased by increasing SL. We found a
main effect of cMyBP-C phosphorylation on length-dependent
changes in pCa50 (Table 1), which was likely due to the
less pronounced length-dependent increase in pCa50 in the
3SA group under basal conditions (Table 1). PKA treatment
significantly reduced pCa50 at both long and short SL in 3SA and
WTmyocardium. Our results also showed that length-dependent
changes in pCa50 observed in WT and 3SA groups under
basal conditions were no longer apparent after PKA treatment
(Table 1), causing a significant SL-PKA interaction effect.
Cooperativity of force generation, nH, significantly increased at
short SL by ∼40% and by ∼29% when compared to long SL
in the WT and 3SA groups, respectively. Furthermore, PKA
treatment did not impact nH at both SL’s in WT and 3SA groups
(Table 1).
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in the Rate of
XB Detachment (krel)
Our analysis showed that cMyBP-C phosphorylation influences
how PKA modulates SL-dependent changes in krel(three-way
interaction effect). Decreasing SL from 2.1 to 1.9µm significantly
accelerated krel by ∼35% in WT myocardium but no effect on
krel was observed in 3SA myocardium, suggesting an abolished
length-dependent modulation of krel (Table 2; Figure 4A). In
addition, PKA treatment significantly accelerated krel by∼52% at
long SL in WT myocardium but not in 3SA myocardium. PKA-
mediated accelerations in krel were not observed at short SL in
either the WT or the 3SA group (Table 2), perhaps suggesting
that in these conditions, XB detachment may have approached
its maximal rate. The three-way interaction effect on krel was due
to the fact that the acceleration in krel observed at short SL in the
WT group under basal conditions was absent in the 3SA group
(Table 2; Figure 4A).
A notable finding was that krel was significantly slower by∼66
and ∼88% in the 3SA group when compared to the WT
group at long and short SL, respectively, under basal conditions
(Figure 4A, Table 2). The slowing of krel in the 3SA group was
also evident following PKA treatment: krel was ∼135 and ∼67%
slower when compared to the WT group at long and short SL,
respectively (Table 2). Collectively, our data demonstrate that
ablation of basal cMyBP-C phosphorylation by itself is sufficient
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FIGURE 2 | Western Blot and Pro-Q analysis to assess the phosphorylation status of myofilament filament proteins in WT and 3SA myocardium. (A)
Western blots showing cMyBP-C and cTnI phosphorylation prior to and following PKA treatment in WT and 3SA heart samples. cTnI phosphorylation at residues
Ser23/24 was similar between WT and 3SA samples under basal conditions (-PKA) and also following PKA treatment. cMyBP-C phosphorylation at residues Ser273,
Ser282, and Ser302 was absent in 3SA heart samples, and their phosphorylation levels were enhanced in the WT samples following PKA incubation. (B)
Representative Pro-Q Diamond-stained (right) and Coomassie-stained (left) SDS gels showing the expression and phosphorylation status of myofilament proteins prior
to and following PKA treatment in WT and 3SA heart samples. (C) Quantification of protein phosphorylation in WT and 3SA hearts as determined by Pro-Q Diamond
staining. The intensity of the phosphorylation signal was normalized to the intensity of the total protein signal and the untreated WT myofibril protein phosphorylation
was set to 1 as done in our previous studies (Gresham et al., 2014; Mamidi et al., 2015). cMyBP-C phosphorylation was enhanced following PKA treatment in WT
samples but not in 3SA samples. No differences in phosphorylation of other myofilament proteins were observed between WT and 3SA samples under basal
conditions and following PKA treatment. cTnI phosphorylation was significantly enhanced following PKA treatment in both WT and 3SA samples. Basal
phosphorylation levels of cMyBP-C (no PKA) observed in 3SA hearts was similar to that reported in an earlier study (Tong et al., 2008). Myofibrils were isolated from 5
to 6 hearts for quantification of protein phosphorylation in WT and 3SA groups. Asterisks in (C) indicate statistical differences when compared to the corresponding
pre PKA WT group. WT, wild-type; cMyBP-C, cardiac myosin binding protein-C; 3SA, non-phosphorylatable cMyBP-C; cTnT, cardiac troponin T; cTnI, cardiac
troponin I; RLC, regulatory light chain.
TABLE 1 | Steady-state contractile parameters measured in WT and 3SA skinned myocardium.
Group pCa50 nH Fmax(mN/mm
2) Fmin(mN/mm
2)
SL 1.9µm
WT (−PKA) 5.79 ± 0.02 (13) 3.49 ± 0.18 (13) 12.21 ± 1.44 (13) 0.33 ± 0.04 (13)
WT (+PKA) 5.74 ± 0.01 (10)* 3.38 ± 0.43 (10) 11.25 ± 1.38 (10) 0.43 ± 0.08 (10)
3SA (−PKA) 5.83 ± 0.01 (11) 3.59 ± 0.20 (11) 12.98 ± 1.70 (11) 0.45 ± 0.09 (11)
3SA (+PKA) 5.76 ± 0.03 (11)* 3.05 ± 0.19 (11) 11.24 ± 1.41 (11) 0.46 ± 0.10 (11)
SL 2.1µm
WT (−PKA) 5.86 ± 0.01 (17)† 2.49 ± 0.12 (17)† 18.99 ± 1.73 (17)† 1.16 ± 0.10 (17)†
WT (+PKA) 5.75 ± 0.01 (12)* 2.86 ± 0.16 (12) 17.83 ± 1.79 (12)† 1.12 ± 0.16 (12)†
3SA (−PKA) 5.88 ± 0.01 (11)† 2.78 ± 0.26 (11)† 20.22 ± 2.70 (11)† 1.50 ± 0.20 (11)†
3SA (+PKA) 5.78 ± 0.01 (12)* 2.80 ± 0.20 (12) 20.22 ± 3.65 (12)† 1.15 ± 0.21 (12)†
pCa50, myofilament Ca
2+ sensitivity; nH, cooperativity of force production; Fmax , maximal Ca
2+ activated force measured at pCa 4.5; Fmin, Ca
2+ independent force measured at pCa
9.0. A minimum of 4 hearts per group were used, and the number of preparations for each group is presented in brackets. Values are expressed as mean ± S.E.M.
*Significantly different compared to the corresponding (-PKA) group at the same SL.
†Significantly different compared to the corresponding group at short SL; asterisks indicate P < 0.05.
to significantly slow krel, and the inability to phosphorylate
cMyBP-C blunts the PKA-mediated accelerations in XB cycling
rates.
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in the
Magnitude of XB Detachment (P2)
The amplitude of P2 was measured to estimate the magnitude
of XB detachment following stretch (see Materials and Methods;
Figure 1A). As reported earlier (Stelzer et al., 2006d), PKA
treatment decreased P2 values (i.e., produced more negative
P2 values) at both SL’s in the WT group but not in the 3SA
group—leading to a significant PKA-cMyBP-C phosphorylation
interaction effect (Table 2; Figure 1). The significant reduction
of the PKA-mediated increase in the magnitude of XB
detachment in 3SA myocardium following stretch suggests
that cMyBP-C phosphorylation likely removes an inhibitory
brake on XB cycling that facilitates accelerated XB detachment
from actin.
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FIGURE 3 | Effect of PKA treatment on myofilament Ca2+ sensitivity (pCa50) in WT and 3SA skinned myocardium. Force-pCa relationships were
constructed by plotting normalized forces generated by incubating the myocardial preparations in a range of pCa prior to and following PKA treatment. Effect of PKA
treatment on the force-pCa relationships in WT preparations at (A) long SL, and (B) short SL. Effect of PKA treatment on the force-pCa relationships in 3SA
preparations at (C) long SL, and (D) short SL. PKA treatment resulted in a significant right-ward shift (decrease in pCa50) in the force-pCa relationships in all the
groups (values are shown in Table 1). The number of preparations used for each group are shown in Table 1. A minimum of 4 hearts per group were used with
multiple preparations from each heart.
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in Muscle
Fiber Stiffness (P1)
We measured the magnitude of the elicited instantaneous
increase in force in response to the imposed stretch (i.e., P1 in
Figure 1), an index of muscle fiber stiffness (Mamidi et al., 2015).
Under basal conditions, decreasing SL significantly decreased P1
by ∼16% and ∼13% in the WT and 3SA groups, respectively
(Table 2). Most importantly, PKA treatment decreased P1
by ∼21% and ∼14% at long and short SL’s in the WT, but
had no effect on P1 in the 3SA group (Figure 5; Table 2)—
contributing to the PKA-cMyBP-C phosphorylation interaction
effect (Table 2).
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in the
Amplitude of Phase 3
P3 is measured from pre-stretch steady state force to the peak
value of the delayed force development in phase 3 (Figure 1A). P3
is the resultant new steady-state force attained in response to the
imposed stretch and is due to the recruitment of additional XBs
into the force-bearing state following the stretch inmuscle length.
Following PKA treatment, Pdf values exceed P3 values (Stelzer
et al., 2006c), as P2 values are often negative, therefore, under
these conditions Pdf represents the entire amplitude of Phase 3
taking into account all XBs recruited into the force-bearing state
following acute stretch (Stelzer et al., 2006d). P3 was decreased
by ∼35% at short SL compared to long SL in WT group under
both basal conditions and following PKA treatment (Table 2).
Likewise, P3 decreased by ∼31 and ∼25% at short SL compared
to long SL in 3SA group under basal conditions and following
PKA treatment, respectively (Table 2). No significant differences
were observed in P3 between WT and 3SA groups under any of
the conditions studied.
Pdf was increased by ∼40 and ∼60% at long SL compared to
short SL in the WT group under basal conditions and following
PKA treatment, respectively (Figure 7; Table 2). Likewise, Pdf
increased by ∼61 and ∼76% at long SL compared to short SL
in the 3SA group under basal conditions and following PKA
treatment, respectively (Figure 7; Table 2). As reported earlier
(Stelzer et al., 2006d), Pdf was significantly enhanced in WT
skinned myocardium following PKA treatment at long and
short SL (∼56 and ∼36%, respectively; Table 2), indicating that
PKA phosphorylation increases the overall magnitude of XB
recruitment when considering an increase in the number of
detached XBs following stretch (i.e., increased P2). The amplitude
of Phase 3 (Pdf) in the 3SA group was significantly lower
compared to the WT group at both SL’s under basal conditions,
and following PKA treatment (Figure 7). The enhancement in
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FIGURE 4 | Effect of cMyBP-C phospho-ablation on SL- and PKA-dependent changes in the rate of XB detachment (krel). Isometrically-contracting
myocardial preparations were subjected to a sudden 2% stretch in muscle length and the elicited force responses at ∼35% of maximal Ca2+ activation level were
used to measure (A) krel under basal conditions (-PKA) and (B) krel following PKA treatment at short and long SL’s in WT and 3SA groups. WT preparations displayed
significant accelerations in krelat short SL compared to long SL under basal conditions, however, no acceleration in krel was observed in 3SA preparations—indicating
that SL-dependent changes in XB detachment are abolished in cMyBP-C phospho-ablated skinned myocardium. Furthermore, krelwas significantly slower in the 3SA
preparations compared to WT preparations at both short and long SL’s under basal conditions and following PKA treatment—indicating that the rate of XB
detachment was significantly slowed in cMyBP-C phospho-ablated skinned myocardium. Values are expressed as mean ± S.E.M. The number of preparations used
for each group are shown in Table 2. A minimum of 3 hearts per group were used with multiple preparations from each heart. *P < 0.05.
FIGURE 5 | Effect of cMyBP-C phospho-ablation on SL- and PKA-dependent changes in the magnitude of sudden-stretch induced increase in the XB
stiffness (P1). P1 was calculated from the force responses elicited due to a sudden 2% stretch in muscle length imposed on isometrically-contracting myocardial
preparations at ∼35% of maximal Ca2+ activation level (Stelzer et al., 2006c) in (A) WT, and (B) 3SA myocardial preparations. PKA treatment significantly decreased
P1 at both SL’s in WT preparations but not in 3SA preparations—indicating that PKA-dependent changes in P1 are abolished in cMyBP-C phospho-ablated skinned
myocardium. Values are expressed as mean ± S.E.M. The number of preparations used for each group are shown in Table 2. A minimum of 3 hearts per group were
used with multiple preparations from each heart. *P < 0.05.
Pdf that was observed following PKA treatment at both SL’s in the
WT group, was not observed in the 3SA group (Table 2) resulting
in a significant PKA-cMyBP-C phosphorylation interaction
effect.
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in the Rate of
XB Recruitment (kdf)
Decreasing SL significantly accelerated kdf by ∼94 and ∼71%
in the WT and 3SA groups, respectively (Table 2; Figure 6).
Following PKA treatment, kdf was significantly accelerated by
∼107 and ∼102% at short SL in the WT and 3SA groups,
respectively (Table 2; Figure 6). Furthermore, PKA treatment
significantly accelerated kdf by ∼35% and by ∼44% at long
and short SL in the WT group, respectively (Figure 6A). Under
basal conditions kdf was not different between the WT and
3SA groups at either SL (Table 2). In contrast to the WT
group, PKA treatment did not induce acceleration in kdf in
the 3SA group at either SL (Figure 6B). As a result, differences
in kdf that were not apparent between the WT and 3SA
groups under basal conditions became apparent following PKA
treatment (Table 2)—resulting in a significant PKA-cMyBP-C
phosphorylation interaction effect.
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in the Rate of
Force Redevelopment (ktr)
Decreasing SL significantly accelerated ktr at submaximal Ca
2+-
activation in both the WT and 3SA groups under basal
conditions, and following PKA treatment (Table 2). In addition,
PKA treatment significantly accelerated ktr at both SL’s in theWT
group, but a PKA-mediated acceleration in ktr was not observed
in the 3SA group (Table 2).
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FIGURE 6 | Effect of cMyBP-C phospho-ablation on SL- and PKA-dependent changes in the rate of XB recruitment (kdf). Isometrically-contracting
myocardial preparations were subjected to a sudden 2% stretch in muscle length at ∼35% of maximal Ca2+ activation level and the elicited force responses were
used to measure kdf in (A) WT, and (B) 3SA myocardial preparations. Decreased SL accelerated kdf under basal conditions and following PKA treatment in both WT
and 3SA preparations. PKA treatment significantly accelerated kdf at both short and long SL’s in the WT group, but not in the 3SA group—indicating that PKA-induced
accelerations in the rate of XB recruitment are abolished in cMyBP-C phospho-ablated skinned myocardium. Values are expressed as mean ± S.E.M. The number of
preparations used for each group are shown in Table 2. A minimum of 3 hearts per group were used with multiple preparations from each heart. *P < 0.05.
DISCUSSION
The heart is tuned to adjust its stroke volume to match systemic
demands on a beat-to-beat basis. Increased sympathetic drive in
response to increased circulatory demands enhances ventricular
filling and results in increased cardiac output. Accordingly, the
Frank-Starling relationship and its underlying mechanisms of
LDA are influenced by an interplay between increased ventricular
filling (corresponding to increased myofilament sarcomere
length (SL)) and increased cardiac output, and are enhanced by
increased β-adrenergic stimulation which leads to XB cycling
(Tong et al., 2008). cMyBP-C is a principal target of increased
β-adrenergic stimulation via PKA phosphorylation, however,
the role of cMyBP-C phosphorylation in modulating length-
dependent changes in XB kinetics in cardiac muscle is poorly
understood. Impaired modulation of LDA is a common feature
of human heart failure, and is often accompanied by reduced
myofilament protein phosphorylation, including cMyBP-C (El-
Armouche et al., 2007; Jacques et al., 2008; Copeland et al., 2010;
Van Dijk et al., 2012). Because cMyBP-C phosphorylation has
been shown to be cardioprotective (Sadayappan et al., 2006)
and plays an important role in modulating XB kinetics (Stelzer
et al., 2006d), cMyBP-C dephosphorylation could underlie the
impaired LDA observed in conditions of heart failure. To
determine the precise molecular mechanisms by which cMyBP-
C phosphorylation regulates length-dependent changes in XB
kinetics, we performed stretch-activation experiments in skinned
myocardium isolated from WT and cMyBP-C phospho-ablated
(i.e., 3SA) hearts, at variable SL, prior to and following PKA
treatment. Results from this study provide the first evidence
of a molecular mechanism by which decreased cMyBP-C
phosphorylation results in impaired modulation of length-
dependent changes in XB kinetics. Specifically, we demonstrate
that cMyBP-C phospho-ablation significantly attenuated the
acceleration of the rate of XB detachment due to reduced SL
and PKA phosphorylation. Furthermore, cMyBP-C phospho-
ablation significantly blunted the magnitude of cooperative
XB recruitment and abolished PKA-mediated accelerations in
the rate of XB recruitment (Table 2). These effects would be
predicted to significantly reduce the ability of the heart to
enhance its cardiac output in conditions of increased sympathetic
drive, and suggest that decreased cMyBP-C phosphorylation
contributes to a depressed Frank-Starling relationship, thereby
contributing to impaired contractile function in failing hearts.
Effect of cMyBP-C Phospho-Ablation on
Length-Dependent Changes in
Steady-State Contractile Function
It is well established that increased SL results in increased
sensitivity of the myofilaments to Ca2+-activation (Kentish
et al., 1986; Dobesh et al., 2002), and this phenomenon is
modulated by PKA-mediated phosphorylation of myofilament
contractile proteins (Konhilas et al., 2003; Wijnker et al., 2014).
Furthermore, increased SL leads to increased force generation,
in part by decreasing the distance between myosin heads and the
thin filament, which enhances cooperative XB recruitment (Moss
et al., 2004) because of an increased probability of actomyosin
interaction due to the closer juxta-position of XB to the thin
filament. In this context, we have recently shown that skinned
myocardium lacking cMyBP-C, which results in a reduced
distance between actin and myosin that promotes XB binding
to the thin filament (Colson et al., 2007), displays a blunted
reduction of the Ca2+-sensitivity of force generation due to
decreases in SL (Mamidi et al., 2014). Using skinnedmyocardium
lacking cMyBP-C, previous studies have suggested a role for
cMyBP-C in modulating reductions in Ca2+-sensitivity of force
due to decreased SL and PKA treatment (Cazorla et al., 2006;
Chen et al., 2010). A recent study utilized myocytes expressing
phospho-ablated cMyBP-C and demonstrated that cMyBP-C
contributes to changes in myofilament Ca2+-sensitivity when
SL is varied between 1.9 and 2.3µm (Kumar et al., 2015). The
molecular mechanisms for these effects are unclear, however,
it was proposed that blunted length-dependent changes in
pCa50 following cMyBP-C phospho-ablation may be related to
a disruption in the binding of the N-domain of cMyBP-C to
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actin, for which it competes with both the inhibitory domain
of cTnI and myosin heads in a phosphorylation and length-
dependent manner (Kumar et al., 2015). We found no significant
differences in the maximal force generation, half-maximal force
(i.e., pCa50) and cooperativity of force generation between 3SA
and WT skinned myocardium at baseline (no PKA) or following
PKA treatment (Table 1) within a range of SL of 1.9–2.1µm.
Furthermore, in contrast to earlier studies (Cazorla et al., 2006;
Lee et al., 2010), we found that length-dependent increases in
Ca2+-sensitivity when SL was increased were abolished following
PKA treatment in both WT and 3SA skinned myocardium
(Table 1). The reasons for these disparities are unclear; however,
they may be due to the narrower range of SL employed in
the present study (1.9–2.1µm) compared to previous studies
(1.9–2.3µm), which may have reduced the overall magnitude
of the shift in Ca2+-sensitivity when SL is increased. However,
in agreement with a recent study (Kumar et al., 2015), we
observed a main effect of cMyBP-C phosphorylation on length-
dependent changes in Ca2+-sensitivity. This suggests that
abolishing cMyBP-C phosphorylation blunts the reduction of the
myofilament sensitivity to Ca2+ (pCa50) in response to reduced
SL (Table 1).
cMyBP-C Phospho-Ablation Significantly
Slows the Basal Rate of XB Detachment
(krel) and Abolishes the SL- and PKA-based
Effects on krel
Because krel is the rate limiting step in the XB cycle assuming a
two-state XB model and under loaded conditions (Strang et al.,
1994), krel is a key determinant of in vivo force generation
(Biesiadecki et al., 2014). Changes in the rate of XB detachment
affect XB cycling at the myofilament level, and consequently
impact rates of systolic pressure development and diastolic
pressure relaxation at the whole-heart level (Gresham et al., 2014;
Gresham and Stelzer, 2016). Previous studies have shown that
krel is significantly accelerated following PKA-mediated cMyBP-
C phosphorylation (Stelzer et al., 2006d), and that cMyBP-C
phospho-ablation eliminates the PKA-mediated acceleration of
the rate of XB detachment (Tong et al., 2008). In addition,
we recently showed that ablation of cMyBP-C prevents the
acceleration in krel due to decreased SL that is observed in
WT skinned myocardium (Mamidi et al., 2014), suggesting that
cMyBP-C is required for length-dependent modulation of XB
detachment from the thin filament. Measurements from human
heart failure samples suggest that cMyBP-C phosphorylation
can also contribute to length-dependent acceleration of the
rate of XB detachment, as myocardium isolated from patients
with hypertrophic cardiomyopathy (HCM) displayed reduced
cMyBP-C phosphorylation exhibited impaired LDA (Sequeira
et al., 2013). However, the mechanism by which cMyBP-C
phosphorylation modulates the length-dependent acceleration of
the rate of XB detachment in the myocardium remains unclear.
In this study, we show that cMyBP-C phospho-ablation
significantly slows krel at long and short SL, both at baseline
and following PKA treatment (Table 2) when compared to WT
skinned myocardium (Figure 4). As shown previously (Tong
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et al., 2008), we also observed a PKA-mediated acceleration
of krel at long SL in WT skinned myocardium that was
abolished in 3SA skinned myocardium (Table 2). PKA treatment
reduced XB stiffness (P1) (Figure 5) and produced more
negative values for P2 in WT skinned myocardium indicating
that PKA phosphorylation facilitates XB detachment from the
thin filament. It has been suggested that P2 amplitude is an
indicator of the reversal of the force-generating step following
stretch, such that more negative P2 values are indicative of
enhanced reversal of the phosphate release step during muscle
contraction (Davis and Epstein, 2003). Enhanced reversibility
of force producing steps in the XB cycle may result in a
functional advantage in themyocardium because XBs can quickly
detach and reattach to the thin filament without increasing
ATP utilization and energy consumption (Davis and Epstein,
2003). Thus, the lack of PKA-mediated decreases in P2 in
3SA skinned myocardium may increase energy utilization and
decrease contractile efficiency, contributing to development of
hypertrophy and systolic dysfunction in vivo.
Slowed XB detachment due to cMyBP-C phospho-ablation
would increase the overall dwell time (i.e., duty ratio) of XBs
bound to the thin filament and consequently delay thin filament
deactivation, which can alter the timing of ventricular relaxation
(Hanft et al., 2008; Biesiadecki et al., 2014). Delayed thin
filament deactivation would be predicted to prolong diastolic
relaxation and slow ventricular filling in vivo (i.e., cause diastolic
dysfunction) during basal function and following increased β-
adrenergic stimulation. Indeed, we recently showed that 3SA
mouse hearts displayed a prolonged time course of pressure
relaxation and an impaired enhancement of the rate of pressure
relaxation in response to β-adrenergic stimulation (Gresham
and Stelzer, 2016). Similarly, a recent study (Rosas et al., 2015)
demonstrated that impaired ventricular relaxation in 3SA hearts
is not due alterations in intracellular Ca2+ transients, strongly
supporting our hypothesis that slowed XB detachment is the
predominant factor underlying diastolic dysfunction in 3SAmice
(Gresham and Stelzer, 2016). Collectively, our data implicates
cMyBP-C phosphorylation as a physiological modulator of
lusitropy in the heart (Lewinter and Palmer, 2015).
cMyBP-C Phospho-Ablation Blunts
PKA-Mediated Accelerations in the Rate of
XB Recruitment (kdf) and Magnitude of the
Delayed Force Transient (Pdf)
It is known that PKA phosphorylation of cMyBP-C enhances
the rate (krel) and magnitude (P2) of XB detachment (Stelzer
et al., 2006d), thereby increasing the number of available
actin binding sites for recruitment and binding of detached
or non-cycling XBs following stretch. Therefore, the absence
of PKA-mediated accelerations in krel or enhancement in P2
at short SL in 3SA skinned myocardium (Figure 4A, Table 2)
would be predicted to also reduce the overall magnitude of
XB recruitment during Phase 3 (i.e., Pdf), and consequently
impair systolic pressure development and ejection in vivo
following β-adrenergic stimulation (Gresham and Stelzer, 2016).
Additionally, impairments in systolic function can directly arise
from defects in XB recruitment mechanisms at the myofilament
level. Consistent with a recent study (Mamidi et al., 2014), here
we observed that the rate of XB recruitment (kdf) was significantly
accelerated at short SL in bothWT and 3SA skinnedmyocardium
(Table 2, Figure 7A). PKA-mediated phosphorylation of cMyBP-
C significantly accelerated kdf at long and short SL in
WT skinned myocardium (Figure 7A), however, PKA-induced
accelerations in kdf were abolished in 3SA skinned myocardium
(Figure 7B), such that following PKA phosphorylation, kdf in
3SA skinned myocardium was significantly slower compared to
WT skinned myocardium (Table 2). To determine if cMyBP-C
phosphorylation also affects the number of XBs recruited into the
force-bearing state in response to changes in SL, we measured the
amplitude of the Phase 3 delayed force redevelopment (Stelzer
and Moss, 2006; Figure 2A). The delayed force redevelopment in
Phase 3 following stretch activation is considered to be primarily
due to the recruitment of additional XBs into the force-bearing
states (Campbell et al., 2004; Linari et al., 2004; Stelzer et al.,
2006c), and varies with the level of Ca2+-activation (Stelzer
et al., 2006c). In the present study we found no differences in
P3 between WT and 3SA groups indicating that the number
of additional XBs recruited above initial pre-stretch steady-state
force was similar (Figure 1A), when the activation levels were
matched. However, because PKA treatment often results in more
negative values in P2 (i.e., greater magnitude of XB detachment,
Stelzer et al., 2006d), the entire magnitude of XB recruitment
of Phase 3 following acute stretch is represented by Pdf which
takes into account the point of transition in the stretch activation
transient where XB recruitment begins to dominate (i.e., P2,
Stelzer et al., 2007a; Figure 1A). Our data show that Pdf was
significantly reduced in 3SA skinned myocardium under all
conditions tested when compared to WT skinned myocardium
(Figure 6; Table 2), indicating that cMyBP-C phospho-ablation
significantly blunts (Table 2) the overall magnitude of stretch-
induced XB recruitment at submaximal Ca2+ activations.
A blunting in the rate and magnitude of XB recruitment
due to cMyBP-C phospho-ablation may be due to the fact that
cMyBP-C phosphorylation alters the dynamic binding between
the thick and thin filaments. cMyBP-C phosphorylation likely
relieves a constraint on myosin heads (Colson et al., 2012;
Pfuhl and Gautel, 2012) which enhances the probability of
actomyosin interactions and accelerates the spread of cooperative
XB recruitment and activation throughout the thin filament
(Kampourakis et al., 2014; Moss et al., 2015) to accelerate the rate
of force development (Moss et al., 2015). Therefore, depressed
rates and magnitude of XB recruitment following PKA treatment
in cMyBP-C phospho-ablated skinned myocardium would be
predicted to significantly slow the rate of force generation at
the myofilament level and diminish the rate of systolic pressure
generation. Indeed, hemodynamic measurements of pressure-
volume relationships in 3SAmice showed a significant slowing in
achieving peak pressure development, and a blunted acceleration
in the rate of pressure development (i.e., reduced dp/dtmax)
following infusion of the β-agonist dobutamine compared toWT
mice (Gresham and Stelzer, 2016). Furthermore, radio-telemetry
measurements of in vivo pressure generation in unanesthetized
3SA mice revealed a significant decrease in the magnitude of
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FIGURE 7 | Effect of cMyBP-C phospho-ablation on SL- and PKA-dependent changes in the magnitude of stretch-induced XB recruitment (Pdf).
Isometrically-contracting myocardial preparations were subjected to a sudden 2% stretch in their muscle length at ∼35% of maximal Ca2+ activation level and the
elicited force responses were used to measure (A) Pdf under basal conditions (-PKA) and (B) Pdf following PKA treatment at short and long SL’s in WT (white bars)
and 3SA (gray bars) groups. Pdf was significantly lower at short SL compared to long SL in the WT and 3SA groups under basal conditions and following PKA
treatment. However, Pdf was significantly lower in the 3SA group compared to WT group at both SL’s under basal conditions and following PKA treatment—indicating
that the overall number of XBs being recruited into the force-bearing state in response to a stretch in muscle length is significantly decreased in cMyBP-C
phospho-ablated skinned myocardium. Values are expressed as mean ± S.E.M. The number of preparations used for each group are shown in Table 2. A minimum
of 3 hearts per group were used with multiple preparations from each heart. *P < 0.05.
peak pressure generation compared to WT mice in response
to an acute dobutamine challenge (Gresham and Stelzer, 2016).
Collectively, these findings from in vivo studies in 3SA hearts
correlate well with a decreased magnitude of XB recruitment
(i.e., decreased Pdf) in 3SA myocardium at the molecular level
(Figure 7; Table 2). The diminished rate and magnitude of
XB recruitment in 3SA skinned myocardium observed here
(Figures 6, 7) in conjunction with reduced rates and magnitude
of peak pressure development following dobutamine infusion
in vivo (Gresham and Stelzer, 2016), suggests that cMyBP-C
phospho-ablation decreases LV peak power generation and
cardiac output. Peak power output in cardiac muscle depends
on the number of force-generating XBs (Mcdonald, 2011), and
is enhanced when strongly-bound XBs prolong thin filament
activation thereby facilitating the recruitment of adjacent XBs
into force-generating states by cooperative mechanisms (Hinken
and Solaro, 2007; Mcdonald, 2011). Thus, cMyBP-C phospho-
ablation appears to decrease peak power output by slowing the
rate of cooperative XB recruitment and limits the number of XBs
recruited to the thin filament.
CONCLUSIONS
Results from the present study demonstrate that cMyBP-C
phosphorylation modulates LDA because cMyBP-C phospho-
ablation resulted in a blunting of SL-dependent decreases in
myofilament Ca2+-sensitivity of force generation (pCa50), and
accelerations in the rate of XB detachment (krel) in 3SA skinned
myocardium. These findings suggest that along with cTnI
phosphorylation, cMyBP-C phosphorylation also contributes
to the modulation of myofilament steady-state force (Chen
et al., 2010; Kumar et al., 2015). Furthermore, our data show
that PKA phosphorylation of both cMyBP-C and cTnI in WT
skinned myocardium result in significant accelerations of the
rates of XB detachment (krel) and XB recruitment (kdf), and
enhancements in the magnitudes of XB detachment (P2) and
recruitment (Pdf). In contrast, in 3SA cMyBP-C phospho-ablated
skinned myocardium where PKA phosphorylation can only
phosphorylate cTnI, we observed a significant blunting in PKA-
mediated accelerations of the rates of XB detachment (krel) and
XB recruitment (kdf), and enhancements in the magnitudes of
XB detachment (P2) and recruitment (Pdf). Thus, cMyBP-C
phosphorylation appears to be the predominant modulator of
the rates of XB detachment and recruitment. Low angle X-ray
diffraction studies reveal that XBs are displaced toward the
actin filament to a similar extent in WT skinned myocardium
where both cTnI and cMyBP-C are phosphorylated by PKA, as
in cTnI PKA-phospho-ablated skinned myocardium in which
only cMyBP-C can be phosphorylated (Colson et al., 2012).
This suggests that the radial disposition of XBs is primarily
mediated by cMyBP-C phosphorylation. The closer juxtaposition
of XBs to actin due to cMyBP-C phosphorylation has been
proposed to be due to a release of the constraint imposed by
cMyBP-C on myosin heads which increases the probability of
XB binding to actin and accelerates cooperative XB recruitment
(kdf) and binding to actin (Colson et al., 2008). The lack
of acceleration of kdf following PKA phosphorylation in 3SA
skinned myocardium along with a diminished magnitude of
XB recruitment (Pdf) would be expected to impair force
generation in conditions of increased β-adrenergic stimulation
in vivo (Gresham and Stelzer, 2016). Furthermore, cMyBP-C
phospho-ablation prevents the acceleration in the rates and
magnitude of XB detachment (krel and P2, respectively) following
PKA phosphorylation and decreased SL (when the cardiac
muscle is shortening during systolic ejection), which would
be expected to delay the force decay in late-systole, thereby,
slowing cardiac pressure relaxation (Gresham and Stelzer, 2016).
The net effect of the acceleration of XB detachment and
recruitment due to cMyBP-C phosphorylation is to decrease XB
duty ratio, which along with cTnI phosphorylation, contributes
to enhanced thin filament deactivation and diminished force
generation.
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Our data demonstrate that cMyBP-C phosphorylation
regulates length-dependent XB kinetics, by modulating the rate
and magnitude of XB detachment and recruitment. Indeed,
we show that cMyBP-C phospho-ablation prevents SL- and
PKA-induced enhancements in the rate and magnitude in
XB detachment, and PKA-induced enhancements in the rate
and magnitude of XB recruitment. Failing human hearts
have a decreased capacity for increasing cardiac output in
conditions of increased systemic demand (Holubarsch et al.,
1996), partly because of a depressed Frank-Starling relationship.
The molecular basis for impaired Frank-Starling relationships
has been proposed to be due to decreased PKA-mediated
myofilament protein phosphorylation (Van Der Velden et al.,
2003; Hanft and Mcdonald, 2009). Here we provide explicit
evidence which shows that cMyBP-C phosphorylation is
an important regulator of length-dependent changes in XB
kinetics and that decreased cMyBP-C phosphorylation may
be an underlying mechanism for depressed Frank-Starling
relationships and cardiac output in human HF. Recent studies
have shown that in human hypertension, which is a common
precursor for development of heart failure with preserved
ejection fraction (HFpEF), cMyBP-C phosphorylation is reduced
and may contribute to a prolongation of XB attachment time
at the myofilament level, thereby impairing diastolic relaxation
(Donaldson et al., 2012). Our finding that cMyBP-C phospho-
ablation significantly slows the rate of XB detachment provides
evidence that indeed, decreased cMyBP-C phosphorylation
in hypertension may be partially responsible for slowed
myofilament XB relaxation and LV diastolic function. Therefore,
our data show that manipulation of cMyBP-C phosphorylation
levels may be an attractive therapeutic strategy for modulating
systolic and diastolic contractile dysfunction in HF.
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